Equity Overview
Price & Market Data
Price: $10.42
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,026,340,800
Daily Volume: 0
Performance Metrics
1 Week: 8.77%
1 Month: 8.77%
3 Months: 8.77%
6 Months: 8.77%
1 Year: -11.32%
YTD: %
Company Details
Employees: 225
Sector: Health technology
Industry: Pharmaceuticals: other
Country:
Details
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.